Glucagon-like peptide 1 agonists: a ray of hope for the treatment of polycystic ovarian syndrome

J Pak Med Assoc. 2023 Dec;73(12):2521-2522. doi: 10.47391/JPMA.9666.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Female
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin
  • Polycystic Ovary Syndrome* / drug therapy

Substances

  • Hypoglycemic Agents
  • Insulin
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor